SCHEMBL7309250

SCHEMBL7309250

COC(=O)Cc1c(O)nc(C)c2cc(OC)c(OC)cc12

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE3B Q13370 1/20 0.44
PDE3A Q14432 1/20 0.44
DCTPP1 Q9H773 1/20 0.42
PDE10A Q9Y233 1/20 0.40
KDM4E B2RXH2 3/20 0.39
GABRA1 P14867 2/20 0.39
GABRA5 P31644 2/20 0.39
GABRA3 P34903 2/20 0.39
GABRA2 P47869 2/20 0.39
GABRA6 Q16445 2/20 0.39
HSP90AB1 P08238 1/20 0.38
GAA P10253 3/20 0.38
KDM5B Q9UGL1 1/20 0.38
RAC1 P63000 2/20 0.37
MEN1 O00255 1/20 0.37
POLB P06746 1/20 0.37
KMT2A Q03164 1/20 0.37
ERAP1 Q9NZ08 1/20 0.37
DPP4 P27487 2/20 0.36
ALDH1A1 P00352 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7305966 0.86 PDE3B (0.57) PDE3BPDE3APDE10AKDM4EGABRA1
SCHEMBL7318410 0.80 PDE3B (0.46) PDE3BPDE3APDE10AKDM4EGABRA1
SCHEMBL7317446 0.79 TP53 (0.44) PDE3BPDE3APDE10AKDM4EPOLB
SCHEMBL7313861 0.77 PDE3B (0.44) PDE3BPDE3APDE10AKDM4EGABRA1
SCHEMBL7312543 0.76 PDE10A (0.37) PDE3BPDE3APDE10AKDM4EGABRA1
SCHEMBL7447294 0.75 KDM4E (0.42) PDE3BPDE3AKDM4EGABRA1GABRA5
SCHEMBL11971485 0.73 PDE10A (0.56) PDE3BPDE3APDE10AKDM4EPOLB
SCHEMBL11971309 0.73 PDE10A (0.56) PDE3BPDE3APDE10AKDM4EMEN1
SCHEMBL6313239 0.73 KDM4E (0.49) PDE3BPDE3APDE10AKDM4EGAA
SCHEMBL12325390 0.73 CYP3A4 (0.46) PDE3BPDE3AKDM4EGAARAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4822800-A Isoquinolinol compounds having cardiotonic and phosphodiesterase fraction III inhibiting properties and/or renal vasodilating properties ORTHO PHARMACEUTICAL CORPORATION (US) 1989-04-18 US claimed